アルツハイマー病治療薬の中国市場

当レポートでは、中国のアルツハイマー病治療薬市場について調査分析し、需要と業界動向の予測や、事業環境、市場参入についての情報を提供しています。

目次

第1章 イントロダクション

• 調査範囲と調査手法
• エグゼクティブサマリー

第2章 事業環境

• 経済の見通し
• 主要経済指標
• 工業生産
• 人口と労働力
• 外国投資
• 外国貿易
• 財務と税金の規制
• 銀行システムと規制
• 外国為替
• 税金と関税

第3章 アルツハイマー病治療薬業界の評価

• アルツハイマー病治療薬業界の構造
• 市場規模
• 市場促進要因
• アルツハイマー病治療薬の販売量
• 主な生産施設の場所と販売量
• 主要生産者の市場シェア
• 人件費
• 潜在的な参入企業
• 主な販売業者
• 主な海外投資
• 技術開発

第4章 アルツハイマー病治療薬の生産と需要

• 概要
• アルツハイマー病治療薬の需要：地域別
• アルツハイマー病治療薬の販売量
• イチョウエキス
• ブレビスカピン
• ガングリオシド
• ドネペジル
• ガランタミン
• ニセルゴリン
• リバスチグミン
• メマンチン
• フペルジンA
• オキシラセタム
• フルナリジン
• ピラセタム
• その他のアルツハイマー病治療薬
• アルツハイマー病治療薬の輸入
• イチョウエキスの輸入
• ブレビスカピンの輸入
• ガングリオシドの輸入
• ドネペジルの輸入
• ガランタミン輸入
• ニセルゴリンの輸入
• リバスチグミン輸入
• メマンチンの輸入
• フペルジンAの輸入
• オキシラセタムの輸入
• フルナリジンの輸入
• ピラセタムの輸入
• その他のアルツハイマー病治療薬の輸入
• 価格動向

第5章 アルツハイマー病治療薬市場の見通し

• アルツハイマー病治療薬市場の見通しの概要
• 政府の規制
• 医療保険業界の概要
• 消費者支出の動向：地域別
• 人口動態の動向
• 医療業界の動向
• 病院と病床
• 医師と受診

第6章 マーケティング戦略

• 中国市場参入の概要
• 中国の流通システム
• アルツハイマー病治療薬の流通チャネル
• 輸送と貨物のインフラ
• コミュニケーション
• 中国市場参入
• ライセンシング
• フランチャイズ
• eコマース
• 商社と現地の代理店
• 駐在員事務所と中国の子会社
• 完全外資企業

第7章 アルツハイマー病治療薬生産者ディレクトリ

• 主なアルツハイマー病治療薬の生産者のプロファイル
• 販売業者・商社
• 協会・研究機関
• 主なエンドユーザー

LIST OF TABLES

I. INTRODUCTION

• Economic Outlook Summary

II. BUSINESS ENVIRONMENT

• Key Economic Indicators
• Industrial Output
• Population and Labor Force Trends
• Foreign Investment and Loans
• Foreign Trade

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer's Disease Drugs Sales Volume
• Major Producer Facility Locations
• Major Alzheimer's Disease Drugs Producer Sales Volume
• Market Share of Key Producers
• Major Foreign Investments

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

• Total Alzheimer's Disease Drugs Sales Volume
• Alzheimer's Disease Drugs Major Producer and Their Market Share
• Ginkgo Bilota Extract Major Producer and Their Market Share
• Breviscapine Major Producer and Their Market Share
• Ganglioside Major Producer and Their Market Share
• Donepezil Major Producer and Their Market Share
• Galanthamine Major Producer and Their Market Share
• Dihydroergotamine Major Producer and Their Market Share
• Rivastigmine Major Producer and Their Market Share
• Memantine Major Producer and Their Market Share
• Huperzine A Major Producer and Their Market Share
• Oxiracetam Major Producer and Their Market Share
• Flunarizine Major Producer and Their Market Share
• Piracetam Major Producer and Their Market Share
• Alzheimer's Disease Drugs Import

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

• Consumer Spending Trend
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

• Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

• China's GDP and Industrial Output
• Industrial Output by Ownership
• China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND

• DEMAND
• Alzheimer's Disease Drugs Sales Volume
• Worldwide Alzheimer's Disease Drugs Demand by Region
• Ginkgo Bilota Extract Sales Volume and Market Share
• Breviscapine Sales Volume and Market Share
• Ganglioside Sales Volume and Market Share
• Donepezil Sales Volume and Market Share
• Galanthamine Sales Volume and Market Share
• Dihydroergotamine Sales Volume and Market Share
• Rivastigmine Sales Volume and Market Share
• Memantine Sales Volume and Market Share
• Huperzine A Sales Volume and Market Share
• Oxiracetam Sales Volume and Market Share
• Flunarizine Sales Volume and Market Share
• Piracetam Sales Volume and Market Share
• Other Alzheimer's Disease Drugs Sales volume and market share
• Alzheimer's Disease Drugs Import Volume
• Ginkgo Bilota Extract Import Volume and Market Share
• Breviscapine Import Volume and Market Share
• Ganglioside Import Volume and Market Share
• Donepezil Import Volume and Market Share
• Galanthamine Import Volume and Market Share
• Dihydroergotamine Import Volume and Market Share
• Rivastigmine Import Volume and Market Share
• Memantine Import Volume and Market Share
• Huperzine A Import Volume and Market Share
• Oxiracetam Import Volume and Market Share
• Flunarizine Import Volume and Market Share
• Piracetam Import Volume and Market Share
• Other Alzheimer's Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

• China's Distribution Channel

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer's Disease Drugs Industry Structure
• Market Size
• Market Growth Drivers
• Alzheimer's Disease Drugs Sales Volume
• Major Producer Facility Locations and Sales Volume
• Market Share of Key Producers
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investments
• Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

• Overview
• Demand of Alzheimer's Disease Drugs by Region
• Alzheimer's Disease Drugs Sales Volume
• Ginkgo Bilota Extract
• Breviscapine
• Ganglioside
• Donepezil
• Galanthamine
• Nicergoline
• Rivastigmine
• Memantine
• Huperzine A
• Oxiracetam
• Flunarizine
• Piracetam
• Other Alzheimer's Disease Drugs
• Alzheimer's Disease Drugs Imports
• Ginkgo Bilota Extract Imports
• Breviscapine Imports
• Ganglioside Imports
• Donepezil Imports
• Galanthamine Imports
• Nicergoline Imports
• Rivastigmine Imports
• Memantine Imports
• Huperzine A Imports
• Oxiracetam Imports
• Flunarizine Imports
• Piracetam Imports
• Other Alzheimer's Disease Drugs Imports
• Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

• Alzheimer's Disease Drugs Markets Outlook Overview
• Government Regulations
• Health Care Insurance Industry Overview
• Consumer Spending Trends By Region
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

V. MARKETING STRATEGIES

• China Market Entry Overview
• China's Distribution System
• Rubber Processing Chemicals Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China's Market Entry
• Licensing
• Franchising
• E-commerce
• Trading Companies and Local Agents
• Representative Offices and Chinese Subsidiaries
• Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

• Major Alzheimer's Disease Drugs Producer Profiles
• Distributors and Trading Companies
• Associations and Research Institutes
• Major End-Users